drugset / Trial / NCT03445169
A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
Phase 1
Completed
16 enrolled
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
RandomizedCrossoverOpen-labelTreatment
Summary
This Phase 1, single-dose study will be conducted in adult male and female subjects (N = 16) who are in general good health and selected for participation in the study according to the selection criteria. This study will assess the effect of food on the pharmacokinetics of belzutifan Tablets. The study will consist of two periods and will be conducted in a crossover fashion.
Timeline
- Start
- 2018-02-23
- Primary completion
- 2018-05-26
- Completion
- 2018-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belzutifan | Small molecule | — | — |
Indications
No indication recorded.